Literature DB >> 2180497

Prognostic value of lymphocyte homing receptor and S phase fraction in non-Hodgkin's lymphoma.

S Jalkanen1, H Joensuu, P Klemi.   

Abstract

Lymphocyte homing receptors (HRs) mediate lymphocyte binding to high endothelial venules, and control their circulation between the blood and the lymphoid organs. The role of HRs and nuclear DNA content in the spread and prognosis of non-Hodgkin's lymphoma was studied from paraffin-embedded tumor sections of 104 patients followed-up for the minimum of 5 years after the diagnosis. HR expression was analyzed by staining with a monoclonal antibody, Hermes-3, and DNA content by flow cytometry. Ten (10%) lymphomas were HR negative (HR-), 14 (13%) weakly (HR+/-), and 80 (77%) strongly positive (HR+). HR- lymphomas disseminated less often than HR+/- or HR+ lymphomas (P = .03), and their prognosis was more favorable (P = .03), although they often had a large S phase fraction (SPF), indicating a rapid proliferation rate. A large SPF (greater than 12%) was strongly associated with an unfavorable histologic type in Working Formulation (P = .0001) and poor survival (P = .006), whereas DNA aneuploidy was not. The 5-year survival rate corrected for intercurrent deaths was 61% in lymphomas with SPF less than 12% or with HR-, but only 15% if SPF was greater than 12% and HR+ (P less than .0001). In multivariate analysis stage (P less than .001), SPF (P = .002) and HR (P = .003) were the only independent prognostic factors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180497

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Lymphocyte homing into the gut.

Authors:  S Jalkanen
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma.

Authors:  S Jalkanen; H Joensuu; K O Söderström; P Klemi
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

3.  Lack of adhesion molecules in testicular diffuse centroblastic and immunoblastic B cell lymphomas as a contributory factor in malignant behaviour.

Authors:  W G Horstmann; W Timens
Journal:  Virchows Arch       Date:  1996-10       Impact factor: 4.064

4.  Expression of the neural cell adhesion molecule (CD56) by human myeloma cells.

Authors:  J Drach; C Gattringer; H Huber
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

5.  Adhesion receptor profile of thymic B-cell lymphoma.

Authors:  A Eichelmann; K Koretz; G Mechtersheimer; P Möller
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

6.  Venular endothelium binding molecules CD44 and LECAM-1 in normal and malignant B-cell populations. A comparative study.

Authors:  P Möller; A Eichelmann; F Leithäuser; G Mechtersheimer; H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

7.  Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.

Authors:  G Koopman; K H Heider; E Horst; G R Adolf; F van den Berg; H Ponta; P Herrlich; S T Pals
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

8.  A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.

Authors:  K H Heider; M Hofmann; E Hors; F van den Berg; H Ponta; P Herrlich; S T Pals
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

9.  Expression of adhesion molecules on myeloma cells.

Authors:  T Tatsumi; C Shimazaki; H Goto; S Araki; Y Sudo; N Yamagata; E Ashihara; T Inaba; N Fujita; M Nakagawa
Journal:  Jpn J Cancer Res       Date:  1996-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.